Tenofovir therapy is associated with increased urinary phosphate excretion and decreased bone mineral density in patients with chronic hepatitis B

被引：0
|
作者：
Le, S. [1 ,2 ]
Wong, P. [3 ,4 ,5 ]
Shochet, I. [6 ]
Doyle, A. [1 ]
Shelton, E. [1 ]
Milat, F. [3 ,4 ,5 ]
Sievert, W. [1 ,2 ]
机构：
[1] Monash Hlth, Dept Gastroenterol & Hepatol, Clayton, Vic 3168, Australia
[2] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia
[3] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[4] Monash Hlth, Dept Endocrinol, Clayton, Vic 3168, Australia
[5] Monash Univ, Dept Med, Southern Clin Sch, Clayton, Vic 3168, Australia
[6] Monash Hlth, Dept Gen Med, Clayton, Vic 3168, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [21] IMPROVEMENT OF BONE MINERAL DENSITY AND MARKERS OF PROXIMAL RENAL TUBULAR FUNCTION IN 12 WEEKS IN CHRONIC HEPATITIS B PATIENTS SWITCHED FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE
    Fong, Tse-Ling
    Lee, Brian T.
    Tien, Andy
    Le, Justin
    Ahn, Aiden
    Kim, Carolina
    Chang, Mimi
    Bae, Ho
    GASTROENTEROLOGY, 2018, 154 (06) : S1133 - S1134
  • [22] Urinary calcium excretion is associated with bone turnover marker in subjects with low bone mineral density.
    Park, J.
    Jung, S.
    Park, T.
    Baek, H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S407 - S407
  • [23] Evaluation of Bone Mineral Density and Bone Turnover Markers in Patients with non-Cirrhotic Chronic Hepatitis B
    Celebi, Guven
    Sarikaya, Selda
    Ozdolap, Senay
    Mungan, Gorkem
    Ankarali, Handan
    Celik, Yavuz
    Akduman, Deniz
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (02): : 324 - 330
  • [24] Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients-author's reply
    Papatheodoridis, George V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 918 - 919
  • [25] Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study (vol 59, pg 239, 2024)
    Ogawa, Eiichi
    Jun, Dae Won
    Toyoda, Hidenori
    Hsu, Yao-Chun
    Yoon, Eileen L.
    Ahn, Sang Bong
    Yeh, Ming-Lun
    Do, Son
    Trinh, Huy N.
    Takahashi, Hirokazu
    Enomoto, Masaru
    Kawada, Norifumi
    Yasuda, Satoshi
    Tseng, Cheng-Hao
    Kawashima, Keigo
    Lee, Han Ah
    Inoue, Kaori
    Haga, Hiroaki
    Do, Ai-Thien
    Maeda, Mayumi
    Hoang, Joseph H.
    Cheung, Ramsey
    Eguchi, Yuichiro
    Ueno, Yoshiyuki
    Furusyo, Norihiro
    Yu, Ming-Lung
    Tanaka, Yasuhito
    Nguyen, Mindie H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (05) : 725 - 725
  • [26] Analysis of Hepatitis B Virus Genotype Changes in Patients with Chronic Hepatitis B Infection on Tenofovir Therapy
    Chauhan, Ranjit
    Singh, Avishek K.
    Rooge, Sheetalnath
    Varshney, Aditi
    Kumar, Manoj
    Sarin, Shiv K.
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (08) : 1364 - 1375
  • [27] Urinary calcium excretion after renal transplant is inversely associated with bone mineral density.
    Coates, PS
    Lim, WH
    Russ, GR
    Coates, PTH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S476 - S476
  • [28] Evaluation of Histological Response in Chronic Hepatitis B Patients with Tenofovir or Entecavir Therapy
    Cercioglu, Duygu
    Kinikli, Sami
    Cesur, Salih
    Ataman Hatipoglu, Cigdem
    Arslan, Kader
    Gonultas, Mehmet
    MIKROBIYOLOJI BULTENI, 2020, 54 (01): : 95 - 109
  • [29] Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?
    Gill, Upkar S.
    Zissimopoulos, Alexandra
    Al-Shamma, Safa
    Burke, Katherine
    McPhail, Mark J. W.
    Barr, David A.
    Kallis, Yiannis N.
    Marley, Richard T. C.
    Kooner, Paul
    Foster, Graham R.
    Kennedy, Patrick T. F.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (03): : 374 - 382
  • [30] INCREASED BONE MINERAL DENSITY IN CHRONIC HEPATITIS C PATIENTS AFTER TREATMENT WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION
    Bunchorntavakul, C.
    Chotiyaputta, W.
    Nimanong, S.
    Chainuvati, S.
    Charatcharoenwitthaya, P.
    Sriussadaporn, S.
    Tanwandee, T.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S451 - S451
12345